Hostname: page-component-77c89778f8-m42fx Total loading time: 0 Render date: 2024-07-19T22:30:20.018Z Has data issue: false hasContentIssue false
  • English
  • Français

Selective Serotonin Reuptake Inhibitors and Trazodone for Treatment of Depression, Psychosis, and Behavioral Symptoms in Patients With Dementia

Published online by Cambridge University Press:  10 January 2005

David L. Sultzer
David L. Sultzer
Affiliation:
Department of Psychiatry and Biobehavioral Sciences, University of California at Los Angeles School of Medicine, Los Angeles, California, USA Mental Health Services, VA Greater Los Angeles Healthcare System, Los Angeles, California, USA.
Get access Rights & Permissions [Opens in a new window]

Extract

Depression, psychosis, agitation, and aggression are fundamental clinical aspects of Alzheimer's disease (AD) and other dementia syndromes. Although behavioral, environmental, and pharmacologic interventions often help ameliorate these symptoms, the efficacy of specific interventions is uncertain, and adverse effects of medications are common.

Type
Pharmacologic Approaches
Information
International Psychogeriatrics , Volume 12 , Issue S1 , July 2000 , pp. 245 - 251
Copyright
© 2000 International Psychogeriatric Association

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)